{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T14:01:34Z","timestamp":1749996094424},"reference-count":33,"publisher":"Japan Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1507\/endocrj.ej18-0052","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T22:24:08Z","timestamp":1537395848000},"page":"1161-1169","source":"Crossref","is-referenced-by-count":2,"title":["A case of ectopic ACTH syndrome due to DDAVP-sensitive but V1b receptor-negative bronchial typical carcinoid with lymphatic metastasis and plasma ProGRP elevation"],"prefix":"10.1507","volume":"65","author":[{"given":"Tadashi","family":"Yamamuro","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kantaro","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Kohara","sequence":"additional","affiliation":[{"name":"Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Nakatsuka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[{"name":"Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunehiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Kansai Rosai Hospital, Amagasaki, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Malerbi DA, Mendon\u00e7a BB, Liberman B, Toledo SPA, Corradini MCM, et al. (1993) The desmopressin stimulation test in the differential diagnosis of Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 38: 463\u2013472.","DOI":"10.1111\/j.1365-2265.1993.tb00341.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Wajchenberg BL, Mendon\u00e7a BB, Liberman B, Pereira M, Carneiro PC, et al. (1994) Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 15: 752\u2013787.","DOI":"10.1210\/edrv-15-6-752"},{"key":"3","unstructured":"3 Wojcik E, Kulpa JK, Sas-Korczynska B, Korzeniowski S, Jakubowicz J (2008) ProGRP and NSE in therapy monitoring in patients with small cell lung cancer. Anticancer Res 28: 3027\u20133033."},{"key":"4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0169-5002(00)00113-6","volume":"29","author":"PJ Lamy","year":"2000","unstructured":"4 Lamy PJ, Grenier J, Kramar A, Pujol JL (2000) Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer. Lung Cancer 29: 197\u2013203.","journal-title":"Lung Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/0169-5002","issn-type":"print"},{"key":"5","unstructured":"5 Molina R, Auge JM, Filella X, Vinolas N, Alicarte J, et al. (2005) Pro-gastrin-releasing peptide (ProGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer. Anticancer Res 25: 1773\u20131778."},{"key":"6","unstructured":"6 Okusaka T, Eguchi K, Kasai T, Kurata T, Yamamoto N, et al. (1997) Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer. Clin Cancer Res 3: 123\u2013127."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 de Keyzer Y, Ren\u00e9 P, Beldjord C, Lenne F, Bertagna X (1998) Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours. Clin Endocrinol (Oxf) 49: 475\u2013482.","DOI":"10.1046\/j.1365-2265.1998.00560.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Luque RM, Ib\u00e1\u00f1ez-Costa A, L\u00f3pez-S\u00e1nchez LM, Jim\u00e9nez-Reina L, Venegas-Moreno E, et al. (2013) A cellular and molecular basis for the selective desmopressin-induced ACTH release in cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications. J Clin Endocrinol Metab 98: 4160\u20134169.","DOI":"10.1210\/jc.2013-1992"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, et al. (2005) Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health. J Clin Endocrinol Metab 90: 4955\u20134962.","DOI":"10.1210\/jc.2004-2527"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, et al. (2011) Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion. Cancer 117: 4381\u20134389.","DOI":"10.1002\/cncr.26029"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Shepherd FA, Laskey J, Evans WK, Goss PE, Johansen E, et al. (1992) Cushing\u2019s syndrome associated with ectopic corticotropin production and small-cell lung cancer. J Clin Oncol 10: 21\u201327.","DOI":"10.1200\/JCO.1992.10.1.21"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Limper AH, Carpenter PC, Scheithauer B, Staats BA (1992) The Cushing syndrome induced by bronchial carcinoid tumors. Ann Intern Med 117: 209\u2013214.","DOI":"10.7326\/0003-4819-117-3-209"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) Introduction to the 2015 World Health Organization Classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol 10: 1240\u20131242.","DOI":"10.1097\/JTO.0000000000000663"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, et al. (1998) Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22: 934\u2013944.","DOI":"10.1097\/00000478-199808000-00003"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, et al. (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24: 70\u201376.","DOI":"10.1200\/JCO.2005.04.1202"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Shrager JB, Wright CD, Wain JC, Torchiana DF, Grillo HC, et al. (1997) Bronchopulmonary carcinoid tumors associated with Cushing\u2019s syndrome: a more aggressive variant of typical carcinoid. J Thorac Cardiovasc Surg 114: 367\u2013375.","DOI":"10.1016\/S0022-5223(97)70182-X"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Sapolsky RM, Donnelly TM (1985) Vulnerability to stress-induced tumor-growth increases with age in rats\u2014role of glucocorticoids. Endocrinology 117: 662\u2013666.","DOI":"10.1210\/endo-117-2-662"},{"key":"18","unstructured":"18 Lointier P, Wildrick DM, Boman BM (1992) The effects of steroid hormones on a human colon cancer cell line <i>in vitro<\/i>. Anticancer Res 12: 1327\u20131330."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Mcdonald TJ, Jornvall H, Nilsson G, Vagne M, Ghatei M, et al. (1979) Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue. Biochem Biophys Res Commun 90: 227\u2013233.","DOI":"10.1016\/0006-291X(79)91614-0"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20 Shibayama T, Ueoka H, Nishii K, Kiura K, Tabata M, et al. (2001) Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC). Lung Cancer 32: 61\u201369.","DOI":"10.1016\/S0169-5002(00)00205-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Sunaga N, Tsuchiya S, Minato K, Watanabe S, Fueki N, et al. (1999) Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer. Oncology 57: 143\u2013148.","DOI":"10.1159\/000012022"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Gong Z, Lu R, Xie S, Jiang M, Liu K, et al. (2016) Overexpression of pro-gastrin releasing peptide promotes the cell proliferation and progression in small cell lung cancer. Biochem Biophys Res Commun 479: 312\u2013318.","DOI":"10.1016\/j.bbrc.2016.09.066"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Korse CM, Taal BG, Bonfrer JMG, Vincent A, van Velthuysen ML, et al. (2011) An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival. Ann Oncol 22: 2625\u20132630.","DOI":"10.1093\/annonc\/mdr007"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Saito M, Tahara A, Sugimoto T (1997) 1-desamino-8-d-arginine vasopressin (DDAVP) as an agonist on V(1b) vasopressin receptor. Biochem Pharmacol 53: 1711\u20131717.","DOI":"10.1016\/S0006-2952(97)00070-1"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1002\/bip.20420"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Tani Y, Sugiyama T, Izumiyama H, Yoshimoto T, Yamada S, et al. (2011) Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors. Endocr J 58: 297\u2013303.","DOI":"10.1507\/endocrj.K10E-389"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Suda T, Kageyama K, Nigawara T, Sakihara S (2009) Evaluation of diagnostic tests for ACTH-dependent Cushing\u2019s syndrome. Endocr J 56: 469\u2013476.","DOI":"10.1507\/endocrj.K08E-353"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Salgado LR, Fragoso MCBV, Knoepfelmacher M, Machado MC, Domenice S, et al. (2006) Ectopic ACTH syndrome: our experience with 25 cases. Eur J Endocrinol 155: 725\u2013733.","DOI":"10.1530\/eje.1.02278"},{"key":"29","unstructured":"29 Tsagarakis S, Tsigos C, Vasiliou V, Tsiotra P, Kaskarelis J, et al. (2002) The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 87: 1646\u20131653."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Val\u00e9ro R, Vallette-Kasic S, Conte-Devolx B, Jaquet P, Brue T (2004) The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing\u2019s disease. Eur J Endocrinol 151: 727\u2013733.","DOI":"10.1530\/eje.0.1510727"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Losa M, Bianchi R, Barzaghi R, Giovanelli M, Mortini P (2009) Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing\u2019s disease. J Clin Endocrinol Metab 94: 3322\u20133328.","DOI":"10.1210\/jc.2009-0844"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 McNicol AM, Murray JE, McMeekin W (1990) Vasopressin stimulation of cell proliferation in the rat pituitary gland <i>in vitro<\/i>. J Endocrinol 126: 255\u2013259.","DOI":"10.1677\/joe.0.1260255"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Manabe S, Shimmyo T, Ando K, Mochizuki A, Takagi M, et al. (2013) A case of a resected typical pulmonary carcinoid with mediastinal lymph node metastasis exhibiting an elevated serum progastrin-releasing peptide (pro-GRP) level. Haigan (Lung cancer) 53: 240\u2013244 (In Japanese).","DOI":"10.2482\/haigan.53.240"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/12\/65_EJ18-0052\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T03:53:59Z","timestamp":1546055639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/65\/12\/65_EJ18-0052\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej18-0052","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}